Neoplasms Trials in Toronto, Canada
Conditions / Neoplasms / Toronto, Canada
Neoplasms has been the subject of sustained clinical investigation across multiple research sites.
76 total trials for this combination
Showing top 10 of 76 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04260802 | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers | TERMINATED | PHASE1/PHASE2 |
| NCT03435796 | Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | RECRUITING | PHASE2/PHASE3 |
| NCT04008797 | A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | TERMINATED | PHASE3 |
| NCT03981796 | A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01964430 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the Apact Study) | COMPLETED | PHASE3 |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | RECRUITING | — |
| NCT02889978 | The Circulating Cell-free Genome Atlas Study | UNKNOWN | — |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | COMPLETED | PHASE1/PHASE2 |